Stay updated on Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.

Latest updates to the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded related topic 'Bladder cancer' and MedlinePlus Genetics link. Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check22 days agoChange DetectedRecruitment status changed from Recruiting to Completed on 2026-03-13, indicating enrollment has finished.SummaryDifference0.3%

- Check29 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedRecruitment status changed from Recruiting to Completed and enrollment updated to 235, with the page revision noted as v3.4.2 on 2026-02-13.SummaryDifference0.4%

- Check58 days agoChange DetectedThe page now shows Revision: v3.4.1, replacing the previous v3.4.0. No substantive content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedRelated topics such as 'Bladder cancer' and 'MedlinePlus Genetics' were removed from the page, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Erdafitinib Intravesical for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erdafitinib Intravesical for Bladder Cancer Clinical Trial page.